All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Lymphoma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene and Roche, and supported through educational grants from Bristol Myers Squibb, Ipsen Biopharmaceuticals, Lilly, Pfizer, and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC View funders.

Won KimScientific Advisory Board Member

Professor Won Kim is a Professor of Hematology and Oncology at the Samsung Medical Center, Sungkyunkwan University, Seoul, KR.

Prof. Kim carried out all of his medical education at the Seoul National University College of Medicine, KR, as well as his clinical fellowship in hematology-oncology. He has also obtained a postdoctoral fellowship from the National Institutes of Health, Maryland, US.

Prof. Kim’s current areas of research interest lie around immunotherapies, small molecule inhibitors, apoptosis, cell cycle, vaccines, and novel agents.

Positions of responsibility/awards:

  • Member of the Korean Society of Hematology
  • Member of the Korean Society of Hematopoietic Stem Cell Transplantation
  • Chair of the Korean Society of Hematology Lymphoma Working Party
  • Chair of the Korean Society of Hematology Scientific Committee
  • Awarded ‘Outstanding Research’ award from the Korean Society of Hematology
  • Awarded ‘Outstanding Senior Researcher’ from the Korean Society of Hematology
  • Awarded ‘Best Academic’ from the Samsung Medical Center
  • Awarded ‘Best for In-patient Care’ from the Samsung Medical Center
|